These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18568722)

  • 1. Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?
    Anderson E; Grant R; Lewis SC; Whittle IR
    Br J Neurosurg; 2008 Jun; 22(3):339-49. PubMed ID: 18568722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment arms summarizing analysis of 220 high-grade glioma studies.
    Hauch H; Sajedi M; Wolff JE
    Anticancer Res; 2005; 25(5):3585-90. PubMed ID: 16101184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for carbon ion therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials.
    Maucort-Boulch D; Baron MH; Pommier P; Weber DC; Mizoe JE; Rochat J; Boissel JP; Balosso J; Tsujii H; Amsallem E
    Cancer Radiother; 2010 Jan; 14(1):34-41. PubMed ID: 20004126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified optimal fractionation for poor prognosis malignant gliomas: an elusive search.
    Gupta T; Dinshaw K
    Acta Oncol; 2005; 44(2):105-13. PubMed ID: 15788288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
    Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
    Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When are "positive" clinical trials in oncology truly positive?
    Ocana A; Tannock IF
    J Natl Cancer Inst; 2011 Jan; 103(1):16-20. PubMed ID: 21131576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies for malignant gliomas: a local affair?
    Rainov NG; Söling A; Heidecke V
    Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross-total resection of malignant gliomas in elderly patients: implications in survival.
    Martinez R; Janka M; Soldner F; Behr R
    Zentralbl Neurochir; 2007 Nov; 68(4):176-81. PubMed ID: 17963194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection bias in clinical trials of anaplastic glioma.
    Winger MJ; Macdonald DR; Schold SC; Cairncross JG
    Ann Neurol; 1989 Oct; 26(4):531-4. PubMed ID: 2684003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted therapies for malignant gliomas: advances and challenges.
    Penas-Prado M; Gilbert MR
    Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy.
    Wakabayashi T; Natsume A; Hashizume Y; Fujii M; Mizuno M; Yoshida J
    J Gene Med; 2008 Apr; 10(4):329-39. PubMed ID: 18220319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
    Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma extent of resection and its impact on patient outcome.
    Sanai N; Berger MS
    Neurosurgery; 2008 Apr; 62(4):753-64; discussion 264-6. PubMed ID: 18496181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy with weekly paclitaxel in malignant cerebral glioma treatment.
    Montemor JP; Peria FM; Monti CR; Petrilli LS; Colli BO; Carlotti Júnior CG
    Onkologie; 2008 Sep; 31(8-9):435-9. PubMed ID: 18787350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameters assessing neurological status in malignant glioma patients: prognostic value for survival and relapse-free time.
    Martinez R; Volter C; Behr R
    Br J Neurosurg; 2008 Aug; 22(4):557-62. PubMed ID: 18686059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
    McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
    Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multivariate analysis of the prognostic factors of grade III gliomas.
    Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
    Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
    Lefebvre JL; Ang KK;
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.